KYMR EPS Estimates
Kymera Therapeutics, Inc.
$108.14
+$1.31(+1.23%)
43
Overall
45
Value
30
Tech
55
Quality
Market Cap
$8.88B
Volume
820.39K
52W Range
$55.26 - $130.05
Target Price
$138.58
KYMR EPS estimates: the consensus estimate for Kymera Therapeutics, Inc.'s current fiscal year is -$3.83 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KYMR EPS Estimates
- EPS estimate, current quarter
- $-1.26
- EPS estimate, next quarter
- $-1.27
- EPS estimate, current year
- $-3.83
- EPS estimate, next year
- $-5.07
- EPS growth, 3-year
- -8.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.69 |
| 2024 | $-2.98 |
| 2023 | $-2.52 |
| 2022 | $-2.87 |
| 2021 | $-2.09 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $108.14 | +1.2% | 820.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW